Wuhan Dahua Weiye Pharmaceutical Co.,Ltd
Wuhan Dahua Weiye Pharmaceutical Co., Ltd is a development-focused enterprise located in Wuhan, China. The company describes itself as a research and development, production and sales entity that was established in 2005. It emphasizes its foundation on advanced technology and modern medical techniques as core components of its business model.
According to available information, the company has more than a decade of experience in its field and highlights its modernization of facilities, experienced staff, and the use of advanced technology. The factory claims to cover more than 2,000 square meters of floor space and includes one pilot plant along with three multipurpose production workshops. The emphasis on scale expansion and ongoing investment in research and development suggests a commitment to growth and long-term product innovation.
Product focus, as described by the company, includes steroids powder, pharmaceutical intermediates, and food additives, reflecting a range of activities within the chemical and pharmaceutical sectors. The company states adherence to quality standards, noting that most of its products have passed ISO 9002 certification and are produced in alignment with GMP standards. This suggests a quality-management approach intended to meet market expectations and regulatory requirements.
Wuhan Dahua Weiye Pharmaceutical Co., Ltd expresses an intention to establish good business relations with customers globally. While the company profile provides insight into its capabilities and quality commitments, specific operational details such as supply chain processes, certifications beyond ISO 9002 and GMP, or international regulatory compliance information are not elaborated in the available material.
Overall, the company presents itself as a mid-sized pharmaceutical development and manufacturing entity with a focus on growth, technological development, and quality assurance, catering to customers within the chemical and pharmaceutical industries. The information available does not include explicit customer sectors, geographic reach, or detailed service offerings beyond its stated product categories and production capabilities.
Note: This profile is derived solely from the provided original profile and does not incorporate additional external data.
Established in 2005, Wuhan Dahua Weiye Pharmaceutical Co., Ltd continues to present itself as a development-driven enterprise with an emphasis on innovation, quality, and expanding capabilities for its domestic and international stakeholders.